Smoking cessation and chronic pain: Patient and pain medicine physician attitudes

Pain Practice

Volumn 11, Issue 6, 2011, Pages 552-563

  Hooten, W Michael ^a   Vickers, Kristin S ^a   Shi, Yu ^c   Ebnet, Kaye L ^b   Townsend, Cynthia O ^a   Patten, Christi A ^a   Warner, David O ^a  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

Chronic pain; Smoking; Smoking cessation

Indexed keywords

OPIATE;

ADULT; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; COGNITION; COPING BEHAVIOR; DISTRESS SYNDROME; DRUG USE; EMOTION; FEMALE; HEALTH BELIEF; HUMAN; KNOWLEDGE; MALE; PAIN ASSESSMENT; PHYSICIAN; PHYSICIAN ATTITUDE; QUALITATIVE RESEARCH; SMOKING; SMOKING CESSATION; TIME;

EID: 80655124717     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2011.00462.x     Document Type: Article

References (74)

1. Hooten WM, Townsend CO, Bruce BK, et al. Effects of smoking status on immediate treatment outcomes of multidisciplinary pain rehabilitation. Pain Med. 2009;10:347-355.
2. Weingarten TN, Moeschler SM, Ptaszynski AE, Hooten WM, Beebe TJ, Warner DO. An assessment of the association between smoking status, pain intensity, and functional interference in patients with chronic pain. Pain Physician. 2008;11:643-653.
3. Weingarten TN, Podduturu VR, Hooten WM, Thompson JM, Luedtke CA, Oh TH. Impact of tobacco use in patients presenting to a multidisciplinary outpatient treatment program for fibromyalgia. Clin J Pain. 2009;25:39-43.
4. Hooten WM, Townsend CO, Bruce BK, Shi Y, Warner DO. Sex differences in characteristics of smokers with chronic pain undergoing multidisciplinary pain rehabilitation. Pain Med. 2009;10:1416-1425.
5. Hooten WM, Townsend CO, Bruce BK, Warner DO. The effects of smoking status on opioid tapering among patients with chronic pain. Anesth Analg. 2009;108:308-315.
6. Fishbain DA, Lewis JE, Cutler RB, Cole B, Rosomoff RS, Rosomoff HL. Does smoking status affect multidisciplinary pain facility treatment outcome? Pain Med. 2007;9:1081-1090.
7. Hellsing AL, Bryngelsson IL. Predictors of musculoskeletal pain in men: a twenty-year follow-up from examination at enlistment. Spine. 2000;25:3080-3086.
8. Vogt MT, Hanscom B, Lauerman WC, Kang JD. Influence of smoking on the health status of spinal patients: the National Spine Network database. Spine. 2002;27:313-319.
9. Fishbain DA, Lewis JE, Gao J, Cole B, Steele Rosomoff R. Are chronic low back pain patients who smoke at greater risk for suicide ideation? Pain Med. 2009;10:340-346.
10. Shi Y, Weingarten TN, Mantilla CB, Hooten WM, Warner DO. Smoking and pain: pathophysiology and clinical implications. Anesthesiology. 2010;113:977-992.
11. Fishbain DA, Lewis JE, Cole B, Cutler RB, Rosomoff HL, Rosomoff RS. Variables associated with current smoking status in chronic pain patients. Pain Med. 2007;8:301-311.
12. Hall SM, Tsoh JY, Prochaska JJ, et al. Treatment for cigarette smoking among depressed mental health outpatients: a randomized clinical trial. Am J Public Health. 2006;96:1808-1814.
13. McFall M, Saxon AJ, Malte CA, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA 2010;304:2485-2493.
14. Townsend CO, Bruce BK, Hooten WM, Rome JD. The role of mental health professionals in multidisciplinary pain rehabilitation programs. J Clin Psychol 2006;62:1433-1443.
15. Israel BA, Schulz AJ, Parker EA, Becker AB. Review of community-based research: assessing partnership approaches to improve public health. Annu Rev Public Health 1998;19:173-202.
16. Cunningham JL, Rome JD, Kerkvliet JL, Townsend CO. Reduction in medication costs for patients with chronic nonmalignant pain completing a pain rehabilitation program: a prospective analysis of admission, discharge, and 6-month follow-up medication costs. Pain Med. 2009;10:787-796.
17. DuPen S, DuPen A. Opioid Conversion Calculator. Poulsbo, WA: Cynergy Group; 2000.
18. Kerns RD, Turk DC, Rudy TE. The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain. 1985;23:345-356.
19. Bernstein IH, Jaremko ME, Hinkley BS. On the utility of the West Haven-Yale Multidimensional Pain Inventory. Spine. 1995;20:956-963.
20. Rudy TE. Multiaxial Assessment of Multidimensional Pain Inventory: Computer Program User's Manual. Pittsburgh, PA: University of Pittsburgh; 1989.
21. Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ. Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol. 1977;106:203-214.
22. Geisser ME, Roth RS, Robinson ME. Assessing depression among persons with chronic pain using the Center for Epidemiological Studies-Depression Scale and the Beck Depression Inventory: a comparative analysis. Clin J Pain. 1997;13:163-170.
23. McCracken LM, Dhingra L. A short version of the Pain Anxiety Symptoms Scale (PASS-20): preliminary development and validity. Pain Res Manag. 2002;7:45-50.
24. Sullivan M, Pivik J. The Pain Catastrophizing Scale: development and validation. Psychol Assess. 1995;7:524-532.
25. McHorney CA, Ware JE Jr., Rogers W, Raczek AE, Lu JF. The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study. Med Care. 1992;30:MS253-MS265.
26. McHorney CA, Ware JE Jr., Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247-263.
27. Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473-483.
28. Ware J. SF-36 Health Survey Manual & Interpretation Guide. Boston, MA: Health Institute, New England Medical Center; 1993.
29. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86:1119-1127.
30. Fagerstrom KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav. 1978;3:235-241.
31. Kozlowski LT, Porter CQ, Orleans CT, Pope MA, Heatherton T. Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI. Drug Alcohol Depend. 1994;34:211-216.
32. Neuendorf KA. The Content Analysis Guidebook. Thousands Oaks, CA: Sage Publications; 2001.
33. Patton M. Qualitative Evaluation and Research Methods. Newbury Park, CA: Sage Publications; 1990.
34. Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today. 2004;24:105-112.
35. Krippendorff K. Content Analysis: An Introduction to its Methodology. London: Sage Publications; 1980.
36. Strang P. Qualitative research methods in palliative medicine and palliative oncology-an introduction. Acta Oncol. 2000;39:911-917.
37. Sim J. Collecting and analysing qualitative data: issues raised by the focus group. J Adv Nurs. 1998;28:345-352.
38. Vickers KS, Hathaway JC, Patten CA, et al. Cancer patients' and patient advocates' perspectives on a novel information source: a qualitative study of the art of oncology, when the tumor is not the target. J Clin Oncol. 2005;23:4013-4020.
39. Warner DO, Klesges RC, Dale LC, et al. Telephone quitlines to help surgical patients quit smoking patient and provider attitudes. Am J Prev Med. 2008;35:S486-S493.
40. McCaul KD, Malott JM. Distraction and coping with pain. Psychol Bull. 1984;95:516-533.
41. Eccleston C. The attentional control of pain: methodological and theoretical concerns. Pain. 1995;63:3-10.
42. Campbell CM, Witmer K, Simango M, et al. Catastrophizing delays the analgesic effect of distraction. Pain. 2010;149:202-207.
43. Bantick SJ, Wise RG, Ploghaus A, Clare S, Smith SM, Tracey I. Imaging how attention modulates pain in humans using functional MRI. Brain. 2002;125:310-319.
44. Tracey I, Ploghaus A, Gati JS, et al. Imaging attentional modulation of pain in the periaqueductal gray in humans. J Neurosci. 2002;22:2748-2752.
45. Verhoeven K, Crombez G, Eccleston C, Van Ryckeghem DM, Morley S, Van Damme S. The role of motivation in distracting attention away from pain: an experimental study. Pain. 2010;149:229-234.
46. Palmer KT, Syddall H, Cooper C, Coggon D. Smoking and musculoskeletal disorders: findings from a British national survey. Ann Rheum Dis. 2003;62:33-36.
47. John U, Hanke M, Meyer C, Volzke H, Baumeister SE, Alte D. Tobacco smoking in relation to pain in a national general population survey. Prev Med. 2006;43:477-481.
48. Edwards R, McElduff P, Harrison RA, Watson K, Butler G, Elton P. Pleasure or pain? A profile of smokers in Northern England. Public Health. 2006;120:760-768.
49. Strine TW, Okoro CA, Chapman DP, et al. Health-related quality of life and health risk behaviors among smokers. Am J Prev Med. 2005;28:182-187.
50. Hooten WM, Shi Y, Gazelka HM, Warner DO. The effects of depression and smoking on pain severity and opioid use in patients with chronic pain. Pain. 2011;152:223-229.
51. Gonzalez A, Hogan J, McLeish AC, Zvolensky MJ. An evaluation of pain-related anxiety among daily cigarette smokers in terms of negative and positive reinforcement smoking outcome expectancies. Addict Behav. 2010;35:553-557.
52. Taly A, Corringer PJ, Guedin D, Lestage P, Changeux JP. Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system. Nat Rev Drug Discov. 2009;8:733-750.
53. Gotti C, Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol. 2004;74:363-396.
54. Simons CT, Cuellar JM, Moore JA, et al. Nicotinic receptor involvement in antinociception induced by exposure to cigarette smoke. Neurosci Lett. 2005;389:71-76.
55. Schmidt BL, Tambeli CH, Gear RW, Levine JD. Nicotine withdrawal hyperalgesia and opioid-mediated analgesia depend on nicotine receptors in nucleus accumbens. Neuroscience. 2001;106:129-136.
56. Zarrindast MR, Khoshayand MR, Shafaghi B. The development of cross-tolerance between morphine and nicotine in mice. Eur Neuropsychopharmacol. 1999;9:227-233.
57. Schmitz JM, Grabowski J, Rhoades H. The effects of high and low doses of methadone on cigarette smoking. Drug Alcohol Depend. 1994;34:237-242.
58. Spiga R, Schmitz J, Day J 2nd. Effects of nicotine on methadone self-administration in humans. Drug Alcohol Depend. 1998;50:157-165.
59. Chait LD, Griffiths RR. Effects of methadone on human cigarette smoking and subjective ratings. J Pharmacol Exp Ther. 1984;229:636-640.
60. Epstein AM, King AC. Naltrexone attenuates acute cigarette smoking behavior. Pharmacol Biochem Behav. 2004;77:29-37.
61. Rukstalis M, Jepson C, Strasser A, et al. Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm. Psychopharmacology (Berl). 2005;180:41-48.
62. Marshall DL, Redfern PH, Wonnacott S. Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine-treated rats. J Neurochem. 1997;68:1511-1519.
63. Corrigall WA, Franklin KB, Coen KM, Clarke PB. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl). 1992;107:285-289.
64. Altier N, Stewart J. The role of dopamine in the nucleus accumbens in analgesia. Life Sci. 1999;65:2269-2287.
65. Fiore MC. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S Department of Health and Human Services, Public Health Service Report; 2008.
66. Prochaska JJ. Integrating tobacco treatment into mental health settings. JAMA. 2010;304:2534-2535.
67. Hall SM, Prochaska JJ. Treatment of smokers with co-occurring disorders: emphasis on integration in mental health and addiction treatment settings. Annu Rev Clin Psychol. 2009;5:409-431.
68. Prochaska JJ, Delucchi K, Hall SM. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. J Consult Clin Psychol. 2004;72:1144-1156.
69. Asher MK, Martin RA, Rohsenow DJ, MacKinnon SV, Traficante R, Monti PM. Perceived barriers to quitting smoking among alcohol dependent patients in treatment. J Subst Abuse Treat. 2003;24:169-174.
70. Martin RA, Rohsenow DJ, MacKinnon SV, Abrams DB, Monti PM. Correlates of motivation to quit smoking among alcohol dependent patients in residential treatment. Drug Alcohol Depend. 2006;83:73-78.
71. Warner DO, Sarr MG, Offord KP, Dale LC. Anesthesiologists, general surgeons, and tobacco interventions in the perioperative period. Anesth Analg. 2004;99:1766-1773.
72. Rechtine GR, Frawley W, Castellvi A, Gowski A, Chrin AM. Effect of the spine practitioner on patient smoking status. Spine. 2000;25:2229-2233.
73. Warner DO. Feasibility of tobacco interventions in anesthesiology practices: a pilot study. Anesthesiology. 2009;110:1223-1228.
74. Watkins EA, Wollan PC, Melton LJ 3rd, Yawn BP. A population in pain: report from the Olmsted County health study. Pain Med. 2008;9:166-174.